View Older Stories
-
Boston Scientific announces pricing of €1.5 billion of senior notes
-
Boston Scientific (BSX) PT Raised to $122 at Citi
-
Citi Reiterates Buy Rating on Boston Scientific (BSX)
-
Buy the dip in this MedTech stock says Citi
-
Citi Reiterates Buy Rating on Boston Scientific (BSX), Top Pick
-
MedTech stocks: Q2 earnings season preview
-
3 MedTech stocks to own - Citi
-
3 MedTech stocks to own for 2024
-
Boston Scientific (NYSE: BSX) Announces Pricing of €2.0 Billion of Senior Notes
-
Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes
-
Privia Health Announces Changes to Board of Directors
-
Citi opens 90-day positive catalyst watch on Boston Scientific (BSX)
-
Boston Scientific to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference
-
Citi Resumes Boston Scientific (BSX) at Buy
-
Citi Opens a Positive Catalyst Watch on DexCom, Negative on Nevro, Cuts Penumbra to Neutral
-
Boston Scientific Announces Pricing Terms of Its Cash Tender Offer
-
Boston Scientific Announces Early Results of Its Cash Tender Offer for Its Outstanding Debt Securities and Increases Aggregate Maximum Principal Amount of Its Cash Tender Offer
-
Boston Scientific Announces Pricing of €3.0 Billion of Senior Notes
-
Boston Scientific (BSX) Announces Cash Tender Offer for up to $2.5B of its Debt
-
Boston Scientific Announces Cash Tender Offer for up to $2.5 Billion of Its Outstanding Debt Securities
-
Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock
-
Boston Scientific (BSX) Prices 25.5M Share Common Offering at $34.25/Sh; Announces Pricing of 8.75M Mandatory Convertible Preferred Offering at $100/Sh
-
Boston Scientific Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock
-
Boston Scientific Prices $1.7 Billion of Senior Notes
-
Boston Scientific (BSX) PT Raised to $42 at Citi, Following Earnings
-
Boston Scientific Announces Pricing Terms of Its Cash Tender Offer for up to $1.0 Billion of Its Outstanding Debt Securities
-
Boston Scientific Announces Early Results of Its Cash Tender Offer for up to $1.0 Billion of Its Outstanding Debt Securities
-
Boston Scientific Announces Cash Tender Offer for Up To $1.0 Billion of Its Outstanding Debt Securities
-
Boston Scientific (BSX) PT Raised to $50 at Citi
-
Boston Scientific (BSX) PT Lowered to $40 at Citi
-
Boston Scientific to Participate in Citi's 2018 Global Healthcare Conference
-
Boston Scientific (BSX) PT Raised to $43 at Citi
-
Exclusive: ValueAct invests $800 million in financial stocks in second quarter - letter
-
Boston Scientific (BSX) PT Raised to $37 at Citi
-
Boston Scientific (BSX) PT Raised to $34 at Citi
-
Boston Scientific Prices $1.0 Billion of Senior Notes
-
Boston Scientific (BSX) PT Raised to $32 at Citi
-
Boston Scientific (BSX) PT Lowered to $31 at Citi
-
Boston Scientific To Participate In Citi 2017 Global Healthcare Conference
-
A Deep Dive into Modeling the TAVR Market: Sell Edward Lifesciences (EW) / Buy Boston Scientific (BSX) - Citi
-
Tepper's Appaloosa Enters American Airlines (AAL), Micron (MU), JC Penney (JCP), Pfizer (PFE) (more...) - 13F
-
Boston Scientific To Participate In Citi 2016 Global Healthcare Conference
-
Notable Mergers and Acquisitions 11/15: (REG)/(EQY) (EL) (BSX) (FINL)
-
Notable Analyst Rating Changes 6/9: (SCTY) (P) (LNKD) Upgraded; (SWKS) (NRG) (CHK) Downgraded
-
Notable Analyst Rating Changes 2/25: (MSCC) (XRAY) (MLNX) Upgraded; (LC) (CNL) (EXAS) Downgraded
-
Halvorsen's Viking Global Entered Biogen (BIIB), McDonald's (MCD), Sold Amazon (AMZN), Citi (C) in Q4 - 13F
-
Viking Global Investors's 13F Shows New Stakes in Aflac (AFL), Calpine (CPN), Southwestern Energy (SWN), Liquidates Hilton (HLT) ...
-
Halvorsen's Viking Global Shows New Stakes in NetFlix (NFLX), 58.com (WUBA), Boston Scientific (BSX), Teva (TEVA) (more...)
-
Citi Starts Boston Scientific (BSX) at Buy
-
Boston Scientific Prices $1.85 Billion Of Senior Notes

